BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 6157423)

  • 41. Purification and characterization of a kinin- and angiotensin II-forming enzyme in the dog heart.
    Sasaguri M; Maeda H; Noda K; Tsuji E; Kinoshita A; Ideishi M; Ogata S; Arakawa K
    J Hypertens; 1997 Jun; 15(6):675-82. PubMed ID: 9218188
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Purification and characterization of an acid protease and vasopeptide kinins from Murphy-Sturm lymphosarcoma.
    Bedi GS; Balwierczak J; Back N
    Adv Exp Med Biol; 1983; 156 (Pt B)():705-26. PubMed ID: 6344582
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. I. Isolation and purification of plasma kallikreins.
    Colman RW; Mattler L; Sherry S
    J Clin Invest; 1969 Jan; 48(1):11-22. PubMed ID: 4974623
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization and purification of a kallikrein from human pancreatic juice and immunological comparison with other kallikreins.
    Amouric M; Figarella C
    Hoppe Seylers Z Physiol Chem; 1979 Mar; 360(3):457-65. PubMed ID: 108189
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Isolation and properties of a new kallikrein inhibitor from Tityus serrulatus venom.
    Ferreira LA; Zingalli R; Habermehl G; Lebrun I
    J Protein Chem; 1998 Nov; 17(8):799-805. PubMed ID: 9988526
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Kinetic analysis of the interaction of human tissue kallikrein with single-chain human high and low molecular weight kininogens.
    Maier M; Austen KF; Spragg J
    Proc Natl Acad Sci U S A; 1983 Jul; 80(13):3928-32. PubMed ID: 6575386
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Purification and characterization of recombinant tissue kallikrein from Escherichia coli and yeast.
    Wang J; Chao J; Chao L
    Biochem J; 1991 May; 276 ( Pt 1)(Pt 1):63-71. PubMed ID: 2039483
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isolation of an enzymatically active glandular kallikrein from human plasma by immunoaffinity chromatography.
    Geiger R; Clausnitzer B; Fink E; Fritz H
    Hoppe Seylers Z Physiol Chem; 1980 Dec; 361(12):1795-803. PubMed ID: 6906311
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Separation of plasma thromboplastin antecedent from kallikrein by the plasma 2 -macroglobulin, kallikrein inhibitor.
    Harpel PC
    J Clin Invest; 1971 Oct; 50(10):2084-90. PubMed ID: 5165598
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anterior pituitary glandular kallikrein: trypsin activation and estrogen regulation.
    Powers CA
    Mol Cell Endocrinol; 1986 Jul; 46(2):163-74. PubMed ID: 3522314
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human tissue kallikrein. I. Isolation and characterization of human pancreatic kallikrein from duodenal juice.
    Hofmann W; Geiger R
    Hoppe Seylers Z Physiol Chem; 1983 Apr; 364(4):413-23. PubMed ID: 6553015
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Specificity of the determination of urinary kallikrein activity using an amidolytic assay].
    Camps J; Costa J; Pérez-Ayuso RM; Rimola A; Arroyo V; Gaya J
    Rev Esp Fisiol; 1983 Sep; 39(3):225-30. PubMed ID: 6197729
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein.
    Harpel PC
    J Exp Med; 1970 Aug; 132(2):329-52. PubMed ID: 4101346
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Partial purification of plasma and tissue kallikreins in psoriatic epidermis.
    Hibino T; Izaki S; Kimura H; Izaki M; Kon S
    J Invest Dermatol; 1988 Apr; 90(4):505-10. PubMed ID: 3351334
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Purification of kininogen II (LMW) from human plasma].
    Díaz A; Henriques OB
    Acta Physiol Lat Am; 1976; 26(4):243-7. PubMed ID: 1032267
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rat urinary kallikrein: purification and properties.
    Silva E; Diniz CR; Mares-Guia M
    Biochemistry; 1974 Oct; 13(21):4304-10. PubMed ID: 4415477
    [No Abstract]   [Full Text] [Related]  

  • 57. Biochemical characterization and substrate specificity of rat prostate kallikrein (S3): comparison with tissue kallikrein, tonin and T-kininogenase.
    Wang C; Tang CQ; Zhou GX; Chao L; Chao J
    Biochim Biophys Acta; 1992 Jun; 1121(3):309-16. PubMed ID: 1320938
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Similarity between a kininogenase (kallikrein) from human large intestine and human urinary kallikrein.
    Zimmermann A; Geiger R; Kortmann H
    Hoppe Seylers Z Physiol Chem; 1979 Dec; 360(12):1767-73. PubMed ID: 260927
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Release of activatable kallikrein by isolated rat kidneys.
    Corthorn J; Roblero J
    Hypertension; 1981; 3(6 Pt 2):II-39-41. PubMed ID: 6913540
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of plasma kallikrein as an activator of latent collagenase in rheumatoid synovial fluid.
    Nagase H; Cawston TE; De Silva M; Barrett AJ
    Biochim Biophys Acta; 1982 Mar; 702(1):133-42. PubMed ID: 6279161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.